These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26786694)

  • 1. Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
    Tobe M; Tsuboi K; Hasegawa F; Fujiwara N; Inoue Y; Isobe M; Isobe Y
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1292-5. PubMed ID: 26786694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
    Inoue Y; Isobe M; Shiohara T; Hayashi H
    Int Arch Allergy Immunol; 2003 Jun; 131(2):143-52. PubMed ID: 12811023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective and curative effects of topically applied CX-659S, a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses.
    Inoue Y; Isobe M; Shiohara T; Goto Y; Hayashi H
    Br J Dermatol; 2002 Oct; 147(4):675-82. PubMed ID: 12366412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of topical CX-659S, a novel diaminouracil derivative, with topical corticosteroid on the three types of allergic responses in mice or guinea pigs.
    Inoue Y; Isobe M; Hayashi H
    J Pharmacol Sci; 2003 Jan; 91(1):71-8. PubMed ID: 12686733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of topically applied CX-659S, a novel diaminouracil derivative, on the contact hypersensitivity reaction in various animal models.
    Goto Y; Inoue Y; Tsuchiya M; Isobe M; Ueno T; Uchi H; Furue M; Hayashi H
    Int Arch Allergy Immunol; 2000 Dec; 123(4):341-8. PubMed ID: 11146392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and activity of a metabolite of (S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (CX-659S).
    Isobe Y; Tobe M; Takahashi O; Goto Y; Inoue Y; Obara F; Tsuchiya M; Hayashi H
    Chem Pharm Bull (Tokyo); 2002 Oct; 50(10):1418-20. PubMed ID: 12372880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction.
    Tobe M; Isobe Y; Goto Y; Obara F; Tsuchiya M; Matsui J; Hirota K; Hayashi H
    Bioorg Med Chem; 2000 Aug; 8(8):2037-47. PubMed ID: 11003148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CX-659S: a novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities.
    Goto Y; Watanabe N; Kogawa N; Tsuchiya M; Takahashi O; Uchi H; Furue M; Hayashi H
    Eur J Pharmacol; 2002 Mar; 438(3):189-96. PubMed ID: 11909611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents.
    Isobe Y; Tobe M; Inoue Y; Isobe M; Tsuchiya M; Hayashi H
    Bioorg Med Chem; 2003 Nov; 11(23):4933-40. PubMed ID: 14604654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration.
    Kido M; Takeuchi S; Esaki H; Hayashida S; Furue M
    J Dermatol Sci; 2010 May; 58(2):130-5. PubMed ID: 20399618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
    Crosignani S; Prêtre A; Jorand-Lebrun C; Fraboulet G; Seenisamy J; Augustine JK; Missotten M; Humbert Y; Cleva C; Abla N; Daff H; Schott O; Schneider M; Burgat-Charvillon F; Rivron D; Hamernig I; Arrighi JF; Gaudet M; Zimmerli SC; Juillard P; Johnson Z
    J Med Chem; 2011 Oct; 54(20):7299-317. PubMed ID: 21916510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
    Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
    Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation of the fermented soy product ImmuBalance™ effectively reduces itching behavior of atopic NC/Tnd mice.
    Matsuda A; Tanaka A; Pan W; Okamoto N; Oida K; Kingyo N; Amagai Y; Xia Y; Jang H; Nishikawa S; Kajiwara N; Ahn G; Ohmori K; Matsuda H
    J Dermatol Sci; 2012 Aug; 67(2):130-9. PubMed ID: 22748506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models.
    Bäumer W; Wlaź P; Jennings G; Rundfeldt C
    Eur J Pharmacol; 2010 Feb; 628(1-3):226-32. PubMed ID: 19917276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modifying pruritus--control of infection. General practice combination therapy of atopic dermatitis].
    Reinhold U
    MMW Fortschr Med; 2000 Aug; 142(33-34):38-40. PubMed ID: 10998901
    [No Abstract]   [Full Text] [Related]  

  • 19. Rutin suppresses atopic dermatitis and allergic contact dermatitis.
    Choi JK; Kim SH
    Exp Biol Med (Maywood); 2013 Apr; 238(4):410-7. PubMed ID: 23760007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Sakurai T; Honma Y; Nakaike S
    Eur J Pharmacol; 2007 Jun; 564(1-3):196-203. PubMed ID: 17328887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.